Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4562 ARTÍCULOS , VIENDO DEL 736 AL 750

Allergy to Carbidopa

Cansino-Torres MA, Sandoval-Rodríguez V, Sáenz-Farret M, Zúñiga-Ramírez C.

Clin Neuropharmacol. 2018 Mar/Apr;41(2):75-79. doi: 10.1097/WNF.0000000000000270.

[New Diagnostic Criteria for Parkinson's Disease: MDS-PD Criteria]

Watanabe H, Hara K, Ito M, Katsuno M, Sobue G.

Brain Nerve. 2018 Feb;70(2):139-146. doi: 10.11477/mf.1416200966.

How Can a Ketogenic Diet Improve Motor Function?

Veyrat-Durebex C, Reynier P, Procaccio V, Hergesheimer R, Corcia P, Andres CR, Blasco H.

Front Mol Neurosci. 2018 Jan 26;11:15. doi: 10.3389/fnmol.2018.00015. eCollection 2018.

Autonomic dysfunction in Parkinson's disease and other synucleinopathies: Introduction to the series

Palma JA.

Mov Disord. 2018 Mar;33(3):347-348. doi: 10.1002/mds.27347. Epub 2018 Feb 13.

Multitarget transcranial direct current stimulation for freezing of gait in Parkinson's disease

Dagan M, Herman T, Harrison R, Zhou J, Giladi N, Ruffini G, Manor B, Hausdorff JM.

Mov Disord. 2018 Apr;33(4):642-646. doi: 10.1002/mds.27300. Epub 2018 Feb 13.

Nigrostriatal dopamine transporter availability in early Parkinson's disease

Fazio P, Svenningsson P, Cselényi Z, Halldin C, Farde L, Varrone A.

Mov Disord. 2018 Apr;33(4):592-599. doi: 10.1002/mds.27316. Epub 2018 Feb 13.

Impairment of cross-modality of vision and olfaction in Parkinson disease

Honma M, Masaoka Y, Kuroda T, Futamura A, Shiromaru A, Izumizaki M, Kawamura M.

Neurology. 2018 Mar 13;90(11):e977-e984. doi: 10.1212/WNL.0000000000005110. Epub 2018 Feb 7.

An investigation into closed-loop treatment of neurological disorders based on sensing mitochondrial dysfunction

Adams SD, Kouzani AZ, Tye SJ, Bennet KE, Berk M.

J Neuroeng Rehabil. 2018 Feb 13;15(1):8. doi: 10.1186/s12984-018-0349-z.

A meta-analysis of diffusion tensor imaging of substantia nigra in patients with Parkinson's disease

Deng XY, Wang L, Yang TT, Li R, Yu G.

Sci Rep. 2018 Feb 13;8(1):2941. doi: 10.1038/s41598-018-20076-y.

[The new tremor classification of the International Parkinson and Movement Disorder Society : Update on frequent tremors]

Gövert F, Becktepe J, Deuschl G.

Nervenarzt. 2018 Apr;89(4):376-385. doi: 10.1007/s00115-018-0489-1.

Effectiveness of Rotigotine plus intensive and goal-based rehabilitation versus Rotigotine alone in "de-novo" Parkinsonian subjects: a randomized controlled trial with 18-month follow-up

Ferrazzoli D, Ortelli P, Riboldazzi G, Maestri R, Frazzitta G.

J Neurol. 2018 Apr;265(4):906-916. doi: 10.1007/s00415-018-8792-0. Epub 2018 Feb 13.

Marketing medicines: charting the rise of modern therapeutics through a systematic review of adverts in UK medical journals (1950-1980)

Green AR, Haddad PM, Aronson JK.

Br J Clin Pharmacol. 2018 Aug;84(8):1668-1685. doi: 10.1111/bcp.13549. Epub 2018 Mar 25.

Proteostasis and the Regulation of Intra- and Extracellular Protein Aggregation by ATP-Independent Molecular Chaperones: Lens α-Crystallins and Milk Caseins

Carver JA, Ecroyd H, Truscott RJW, Thorn DC, Holt C.

Acc Chem Res. 2018 Mar 20;51(3):745-752. doi: 10.1021/acs.accounts.7b00250. Epub 2018 Feb 14.

Voice quality outcomes of idiopathic Parkinson's disease medical treatment: A systematic review

Lechien JR, Blecic S, Huet K, Delvaux V, Piccaluga M, Roland V, Harmegnies B, Saussez S.

Clin Otolaryngol. 2018 Jun;43(3):882-903. doi: 10.1111/coa.13082. Epub 2018 Mar 12.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias